🚀 VC round data is live in beta, check it out!
- Public Comps
- Veradigm
Veradigm Valuation Multiples
Discover revenue and EBITDA valuation multiples for Veradigm and similar public comparables like Artrya, Beijing Sunwayworld, Heren Health, Medley Inc. and more.
Veradigm Overview
About Veradigm
Veradigm Inc is a healthcare technology company that drives value through its various combinations of platforms, data, expertise, connectivity, and scale. The company delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions for the healthcare provider, payer, and Life Science markets.
Founded
2000
HQ

Employees
2.6K
Website
Sectors
Financials (LTM)
EV
$231M
Veradigm Financials
Veradigm reported last 12-month revenue of $586M and EBITDA of $81M.
In the same LTM period, Veradigm generated $330M in gross profit, $81M in EBITDA, and $30M in net income.
Revenue (LTM)
Veradigm P&L
In the most recent fiscal year, Veradigm reported revenue of $588M and EBITDA of $58M.
Veradigm expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $586M | XXX | $588M | XXX | XXX | XXX |
| Gross Profit | $330M | XXX | $308M | XXX | XXX | XXX |
| Gross Margin | 56% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $81M | XXX | $58M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | (3%) | XXX | XXX | XXX |
| Net Profit | $30M | XXX | ($86M) | XXX | XXX | XXX |
| Net Margin | 5% | XXX | (15%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Veradigm Stock Performance
Veradigm has current market cap of $458M, and enterprise value of $231M.
Market Cap Evolution
Veradigm's stock price is $4.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $231M | $458M | 0.0% | XXX | XXX | XXX | $-0.79 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVeradigm Valuation Multiples
Veradigm trades at 0.4x EV/Revenue multiple, and 2.9x EV/EBITDA.
EV / Revenue (LTM)
Veradigm Financial Valuation Multiples
As of April 20, 2026, Veradigm has market cap of $458M and EV of $231M.
Equity research analysts estimate Veradigm's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Veradigm has a P/E ratio of 15.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $458M | XXX | $458M | XXX | XXX | XXX |
| EV (current) | $231M | XXX | $231M | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 2.9x | XXX | 4.0x | XXX | XXX | XXX |
| EV/EBIT | 5.7x | XXX | (11.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| P/E | 15.0x | XXX | (5.3x) | XXX | XXX | XXX |
| EV/FCF | (5.8x) | XXX | 2.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Veradigm Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Veradigm Margins & Growth Rates
Veradigm's revenue in the last 12 month grew by 0%.
Veradigm's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Veradigm's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Veradigm's rule of X is 14% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Veradigm Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | (0%) | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 34% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 14% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 24% | XXX | — | XXX | XXX | XXX |
| R&D Expenses to Revenue | 24% | XXX | 17% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 56% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Veradigm Public Comps
See public comps and valuation multiples for other Healthcare Software and EHR & Practice Management comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Veradigm | XXX | XXX | XXX | XXX | XXX | XXX |
| Artrya | XXX | XXX | XXX | XXX | XXX | XXX |
| Beijing Sunwayworld | XXX | XXX | XXX | XXX | XXX | XXX |
| Heren Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Medley Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| Weave Communications | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Veradigm M&A Activity
Veradigm acquired XXX companies to date.
Last acquisition by Veradigm was on XXXXXXXX, XXXXX. Veradigm acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Veradigm
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVeradigm Investment Activity
Veradigm invested in XXX companies to date.
Veradigm made its latest investment on XXXXXXXX, XXXXX. Veradigm invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Veradigm
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Veradigm
| When was Veradigm founded? | Veradigm was founded in 2000. |
| Where is Veradigm headquartered? | Veradigm is headquartered in United States. |
| How many employees does Veradigm have? | As of today, Veradigm has over 2K employees. |
| Who is the CEO of Veradigm? | Veradigm's CEO is Shih-Yin Ho. |
| Is Veradigm publicly listed? | Yes, Veradigm is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Veradigm? | Veradigm trades under MDRX ticker. |
| When did Veradigm go public? | Veradigm went public in 1999. |
| Who are competitors of Veradigm? | Veradigm main competitors are Artrya, Beijing Sunwayworld, Heren Health, Medley Inc.. |
| What is the current market cap of Veradigm? | Veradigm's current market cap is $458M. |
| What is the current revenue of Veradigm? | Veradigm's last 12 months revenue is $586M. |
| What is the current revenue growth of Veradigm? | Veradigm revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of Veradigm? | Current revenue multiple of Veradigm is 0.4x. |
| Is Veradigm profitable? | Yes, Veradigm is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Veradigm? | Veradigm's last 12 months EBITDA is $81M. |
| What is Veradigm's EBITDA margin? | Veradigm's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Veradigm? | Current EBITDA multiple of Veradigm is 2.9x. |
| What is the current FCF of Veradigm? | Veradigm's last 12 months FCF is ($40M). |
| What is Veradigm's FCF margin? | Veradigm's last 12 months FCF margin is (7%). |
| What is the current EV/FCF multiple of Veradigm? | Current FCF multiple of Veradigm is (5.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.